12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Visterra preclinical data

In mice, single doses of VIS410 given 24 hours before viral challenge led to 100% survival through day 14 after lethal infection with either H1N1 or H3N2 influenza A virus vs. 0% survival...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >